IFP Advisors, Inc - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 261 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$11,436
+530.1%
1,340
+168.0%
0.00%
Q1 2023$1,815
+15025.0%
500
-75.3%
0.00%
Q4 2022$12
-99.9%
2,023
-15.7%
0.00%
Q3 2022$9,0000.0%2,3990.0%0.00%
Q2 2022$9,0000.0%2,3990.0%0.00%
Q1 2022$9,0002,3990.00%
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2019$7,000
+133.3%
1,324
+32.4%
0.00%
Q3 2017$3,0000.0%1,0000.0%0.00%
Q2 2017$3,000
+50.0%
1,0000.0%0.00%
Q1 2017$2,000
+100.0%
1,0000.0%0.00%
Q4 2016$1,0000.0%1,0000.0%0.00%
Q3 2016$1,0000.0%1,0000.0%0.00%
Q2 2016$1,0001,0000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders